ZYCORTAL SUSPENSION 4 ML VINV-DPET-0103

ZYCORTAL® Suspension (desoxycorticosterone pivalate) 4mL is a veterinary prescription medication used as long-term replacement therapy for dogs diagnosed with Addison’s disease (canine hypoadrenocorticism), a condition caused by insufficient production of adrenal hormones. Specifically, it addresses the deficiency in mineralocorticoids, which play a key role in regulating sodium (Na⁺), potassium (K⁺), and fluid balance. While ZYCORTAL does not replace cortisol, it supports the mineralocorticoid component of adrenal function, helping stabilize blood volume and vital systems. Administered via subcutaneous injection by a veterinarian, ZYCORTAL dosage is based on the dog’s body weight and is typically adjusted over time based on clinical response and lab values. It helps manage symptoms associated with hypoadrenocorticism, such as polyuria, polydipsia, depression, vomiting, and weight loss. As the only FDA-approved desoxycorticosterone pivalate product for veterinary use, ZYCORTAL is a trusted alternative to Percorten-V. Injection site reactions like mild swelling or discomfort may occur, but serious hypersensitivity responses are rare. Use with caution in dogs with kidney disease or when administered alongside diuretics due to its sodium-retaining properties. Regular monitoring of electrolytes and the Na⁺/K⁺ ratio is essential to ensure proper dosing and effectiveness throughout the treatment plan. ZYCORTAL should be stored at room temperature, kept out of reach of children, and is not intended for human use. It is available through licensed veterinary pharmacies and should only be administered under the guidance of a veterinarian as part of a comprehensive Addison’s disease management protocol.